Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
imaradenant (AZD4635)
i
Other names:
HTL-1071, HTL 1071, AZD4635, AZD-4635, AZD 4635
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(2)
News
Trials
Company:
AstraZeneca, Nxera Pharma
Drug class:
Adenosine A2A receptor antagonist
Related drugs:
‹
AB928 (2)
EXS21546 (0)
ILB-2109 (0)
INCB106385 (0)
LNC-003 (0)
M1069 (0)
MK-1088 (0)
PORT-6 (0)
CPI-444 (0)
EOS-850 (0)
SCH 420814 (0)
NIR178 (0)
AB928 (2)
EXS21546 (0)
ILB-2109 (0)
INCB106385 (0)
LNC-003 (0)
M1069 (0)
MK-1088 (0)
PORT-6 (0)
CPI-444 (0)
EOS-850 (0)
SCH 420814 (0)
NIR178 (0)
›
Associations
(2)
News
Trials
VERI cancer hierarchy
Reset Filters
PTEN deletion
Prostate Cancer
PTEN deletion
Prostate Cancer
apalutamide + AZD4635
Sensitive: D – Preclinical
apalutamide + AZD4635
Sensitive
:
D
apalutamide + AZD4635
Sensitive: D – Preclinical
apalutamide + AZD4635
Sensitive
:
D
PTEN deletion
Prostate Cancer
PTEN deletion
Prostate Cancer
AZD4635
Sensitive: D – Preclinical
AZD4635
Sensitive
:
D
AZD4635
Sensitive: D – Preclinical
AZD4635
Sensitive
:
D
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login